TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Cardiovascular Diseases
Division of General Internal Medicine
更新時間:2023-09-19
吳卓鍇WU, CHO-KAI
- Principal Investigator
- Clinical Trial Experience (year) 12 years 9 個月
Publication
23Publications
21
Wang, T. D., Lee, Y. H., Chang, S. S., Tung, Y. C., Yeh, C. F., Lin, Y. H., Pan, C. T., Hsu, C. Y., Huang, C. Y., Wu, C. K., Sung, P. H., Chiang, L. T., Wang, Y. C., Tsai, W. C., Lin, T. T., Lin, C. P., Chen, W. J., & Hwang, J. J. (2019). 2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension. Acta Cardiologica Sinica, 35(3), 199-230. https://doi.org/10.6515/acs.201905_35(3).20190415a
22
Wu, C. K., Cheng, J. F., Huang, C. Y., Chen, Z. W., Chen, S. Y., & Lin, L. Y. (2021). Iloprost and exercise haemodynamics in heart failure with preserved ejection fraction-the ILO-HOPE randomised controlled trial. British Journal of Clinical Pharmacology, 87(3), 1165-1174. https://doi.org/10.1111/bcp.14484
23
Wu, C. K., Lee, J. K., Hsu, J. C., Su, M. Y. M., Wu, Y. F., Lin, T. T., Lan, C. W., Hwang, J. J., & Lin, L. Y. (2020). Myocardial adipose deposition and the development of heart failure with preserved ejection fraction. European Journal of Heart Failure, 22(3), 445-454. https://doi.org/10.1002/ejhf.1617